secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-12-02T23:59:59+00:00
Accession:  0001824293-25-000155
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI BIO receives Nasdaq delisting notice for stockholders' equity deficiency
----------------------------------------------------------------------------

- Nasdaq notified GRI BIO of non-compliance with minimum stockholders' equity requirement (Listing Rule 5550(b)(1)).
- As of September 30, 2025, stockholders' equity fell below the required $2.5M threshold.
- Company has 45 days (until January 10, 2026) to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant up to 180 additional calendar days to cure the deficiency.
- Failure to regain compliance or rejection of plan may lead to delisting; company can appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000155/0001824293-25-000155-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000155/val-20251126.htm
  HTML page:      https://secwatch.observer/filing/0001824293-25-000155

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer